DK2468292T3 - Nyt peptid med antisekretorisk aktivitet - Google Patents

Nyt peptid med antisekretorisk aktivitet Download PDF

Info

Publication number
DK2468292T3
DK2468292T3 DK12157100.4T DK12157100T DK2468292T3 DK 2468292 T3 DK2468292 T3 DK 2468292T3 DK 12157100 T DK12157100 T DK 12157100T DK 2468292 T3 DK2468292 T3 DK 2468292T3
Authority
DK
Denmark
Prior art keywords
new peptide
antisecretory activity
antisecretory
activity
peptide
Prior art date
Application number
DK12157100.4T
Other languages
Danish (da)
English (en)
Inventor
Stefan Lange
Eva Jennische
Hans-Arne Hansson
Original Assignee
Lantmaennen Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lantmaennen Medical Ab filed Critical Lantmaennen Medical Ab
Application granted granted Critical
Publication of DK2468292T3 publication Critical patent/DK2468292T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DK12157100.4T 2006-04-27 2007-04-27 Nyt peptid med antisekretorisk aktivitet DK2468292T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0600932 2006-04-27
EP07748079.6A EP2015767B1 (en) 2006-04-27 2007-04-27 Use of antisecretory factor for treating intraocular hypertension

Publications (1)

Publication Number Publication Date
DK2468292T3 true DK2468292T3 (da) 2020-03-23

Family

ID=38561776

Family Applications (2)

Application Number Title Priority Date Filing Date
DK12157100.4T DK2468292T3 (da) 2006-04-27 2007-04-27 Nyt peptid med antisekretorisk aktivitet
DK07748079.6T DK2015767T3 (en) 2006-04-27 2007-04-27 APPLICATION OF ANTISECRETORIC FACTOR TO TREAT INTRAOCULAR HYPERTENSION

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK07748079.6T DK2015767T3 (en) 2006-04-27 2007-04-27 APPLICATION OF ANTISECRETORIC FACTOR TO TREAT INTRAOCULAR HYPERTENSION

Country Status (18)

Country Link
US (2) US8207296B2 (cg-RX-API-DMAC7.html)
EP (2) EP2015767B1 (cg-RX-API-DMAC7.html)
JP (2) JP5284948B2 (cg-RX-API-DMAC7.html)
KR (1) KR20090040404A (cg-RX-API-DMAC7.html)
CN (2) CN102633863B (cg-RX-API-DMAC7.html)
AU (1) AU2007244004B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0710959B8 (cg-RX-API-DMAC7.html)
CA (2) CA2771087C (cg-RX-API-DMAC7.html)
DK (2) DK2468292T3 (cg-RX-API-DMAC7.html)
ES (2) ES2561945T3 (cg-RX-API-DMAC7.html)
IL (1) IL194773A (cg-RX-API-DMAC7.html)
MX (1) MX2008013769A (cg-RX-API-DMAC7.html)
NZ (2) NZ572255A (cg-RX-API-DMAC7.html)
PL (2) PL2015767T3 (cg-RX-API-DMAC7.html)
RU (1) RU2458703C2 (cg-RX-API-DMAC7.html)
SG (1) SG171602A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007126364A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200809115B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG171602A1 (en) * 2006-04-27 2011-06-29 Lantmaennen As Faktor Ab Use of antisecretory factors for treating intraocular hypertension
US9962424B2 (en) 2007-04-27 2018-05-08 Lantmännen As-Faktor Ab Use of antisecretory factors (AF) for optimizing cellular uptake
EP2396024A4 (en) * 2009-02-11 2013-02-27 Lantmaennen As Faktor Ab USE OF ANTISECRREATORY FACTORS (AF) FOR OPTIMIZATION OF CELLULAR ABSORPTION
WO2013050795A1 (en) * 2011-10-03 2013-04-11 Femtonics Kft. Use of photoactive compounds
WO2014096384A1 (en) * 2012-12-20 2014-06-26 Lantmännen As-Faktor Ab Use of antisecretory factor (af) in glioblastoma treatment
JP6707121B2 (ja) 2015-07-10 2020-06-10 ラントメネン・アーエス−ファクトール・アーベー 高含量のａｆ−１６を有する卵黄の産生方法
MX2019000594A (es) 2016-07-18 2019-09-09 Lantmaennen As Faktor Ab Factor anti-secretor 17.
JP7217760B2 (ja) 2018-06-28 2023-02-03 ラントメネン・メディカル・アーベー 急性呼吸不全の治療および／または予防の使用のための抗分泌因子
EP3855935A1 (en) 2018-09-28 2021-08-04 Lantmännen Functional Foods AB A consumable product comprising malted wheat
EP3855934A2 (en) 2018-09-28 2021-08-04 Lantmännen Functional Foods AB A consumable product comprising malted dehulled oat
CN115605214A (zh) 2020-03-26 2023-01-13 兰特门内保健食品公司（Se） 用于促进身体活动恢复的包含麦芽化谷物的可消耗产品
WO2024102346A1 (en) * 2022-11-08 2024-05-16 Aisa Pharma, Inc. Methods of treating eye pain and eye disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH682716A5 (de) 1992-01-13 1993-11-15 Christian Fricker Benzo-Pyrone und/oder Dobesilat-Calcium enthaltende pharmazeutische Zusammensetzung.
US5585401A (en) * 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
SE508609C2 (sv) * 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
JP2000506375A (ja) * 1996-01-26 2000-05-30 エイチエスシー リサーチ アンド デベロップメント リミテッド パートナーシップ アルツハイマー病に関連する核酸およびタンパク質、ならびにその使用
SE506486C2 (sv) * 1996-11-20 1997-12-22 Svenska Lantmaennen Riksfoerbu Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) * 1998-12-17 2000-09-18 Rural Patent Svenska Ab NASP-berikad äggula samt dess användning
MXPA01001885A (es) * 1999-06-21 2002-04-24 Inkine Pharmaceutical Company Angiocidina: un receptor de adhesion a celula tumoral especifico de cys-ser-val-thr-cys-gly.
RU2192898C1 (ru) * 2001-08-16 2002-11-20 Московский научно-исследовательский институт глазных болезней им. Гельмгольца Способ лечения герпетического кератита с изъязвлением
GB0322645D0 (en) * 2003-09-26 2003-10-29 Melacure Therapeutics Ab Use of antisecretory factor peptides
AU2007244005B2 (en) * 2006-04-27 2012-08-02 Lantmannen As-Faktor Ab Further medical uses of antisecretory protein
SG171602A1 (en) * 2006-04-27 2011-06-29 Lantmaennen As Faktor Ab Use of antisecretory factors for treating intraocular hypertension
CN101460187B (zh) * 2006-04-27 2014-11-05 兰特门内阿斯-法克托尔公司 抗分泌蛋白的进一步医疗应用

Also Published As

Publication number Publication date
KR20090040404A (ko) 2009-04-24
CA2771087A1 (en) 2007-11-08
JP2012153695A (ja) 2012-08-16
US20120283191A1 (en) 2012-11-08
NZ572255A (en) 2012-03-30
CN101432013B (zh) 2015-01-07
IL194773A (en) 2015-07-30
ZA200809115B (en) 2009-07-29
US20090162296A1 (en) 2009-06-25
BRPI0710959A2 (pt) 2012-02-28
CA2650344A1 (en) 2007-11-08
CN101432013A (zh) 2009-05-13
CN102633863A (zh) 2012-08-15
RU2458703C2 (ru) 2012-08-20
AU2007244004A1 (en) 2007-11-08
WO2007126364A2 (en) 2007-11-08
MX2008013769A (es) 2009-02-03
JP2009535329A (ja) 2009-10-01
NZ598426A (en) 2012-08-31
EP2468292B8 (en) 2020-02-26
CA2771087C (en) 2016-03-15
US9000125B2 (en) 2015-04-07
SG171602A1 (en) 2011-06-29
AU2007244004B2 (en) 2012-02-09
IL194773A0 (en) 2011-08-01
DK2015767T3 (en) 2016-02-08
CA2650344C (en) 2017-10-31
CN102633863B (zh) 2014-08-06
JP5284948B2 (ja) 2013-09-11
EP2468292A1 (en) 2012-06-27
BRPI0710959B1 (pt) 2018-11-06
RU2008146733A (ru) 2010-06-10
EP2468292B1 (en) 2019-12-18
EP2015767A2 (en) 2009-01-21
US8207296B2 (en) 2012-06-26
WO2007126364A3 (en) 2008-03-06
PL2015767T3 (pl) 2016-05-31
PL2468292T3 (pl) 2020-08-24
BRPI0710959B8 (pt) 2021-05-25
EP2015767B1 (en) 2016-01-06
ES2773945T3 (es) 2020-07-15
ES2561945T3 (es) 2016-03-01
WO2007126364A8 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
DK2468292T3 (da) Nyt peptid med antisekretorisk aktivitet
PL2465864T3 (pl) Szczepionki z peptydem pochodzącym z Eph4
HRP20151120T1 (xx) Polipeptid ace2
DK2171053T3 (da) Natriuretiske polypeptider
HRP20151108T1 (xx) Antagonisti nogo-receptora
DE602005000208D1 (de) Kraftstoffzufuhrsystem
DK2035447T3 (da) Polypeptid
DK2064228T3 (da) Syntetiske peptidamider
DK1661627T3 (da) Dyseanordning
DK2035451T3 (da) Insulinoptrop peptidsyntese
BRPI0911743A2 (pt) "peptídeo"
DE602005015131D1 (de) Interleukin-15-antagonistisches peptid
ITMI20041573A1 (it) Fluoroelastomeri
DK2402364T3 (da) Et nonapeptid med anti-tumor aktivitet
FR2910401B1 (fr) Appui-tete escamotable
DK2195435T3 (da) Trichoderma-promoter
DE602005002290D1 (de) Kraftstoffschlauch
DK1968623T3 (da) Bacteriocin-inducer-peptider
DE502006004022D1 (de) Einspritzdüse
ITTO20050022A1 (it) Impianto di alimentazione del carburante
FI20050753L (fi) Uudet peptidit
FR2910406B1 (fr) Appui-tete escamotable
FI20075483A0 (fi) Uusi peptidi
DK2081952T3 (da) Peptider
BRPI0812530A2 (pt) peptídeo tendo atividade hipotensiva